$3.17
-0.06-1.86%
At close: -
$3.17
N/A
After Hours: 4:00 PM EDT
Comments
Loading...
Rocket Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:RCKT | Benzinga
Rocket Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 6
EPS
$-0.450
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Rocket Pharmaceuticals using advanced sorting and filters.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
RCKT | Rocket Pharmaceuticals | -$0.71 | -$0.50 | -$0.45 | 10.00% | $0.00 | $250.00K | $0.00 | -100.00% | 11/06/2025 | |
RCKT | Rocket Pharmaceuticals | -$0.74 | -$0.55 | -$0.62 | -12.73% | $0.00 | $4.36M | $0.00 | -100.00% | 08/07/2025 | |
RCKT | Rocket Pharmaceuticals | -$0.66 | -$0.58 | -$0.56 | 3.45% | $0.00 | $800.00K | $0.00 | -100.00% | 05/08/2025 | |
RCKT | Rocket Pharmaceuticals | -$0.64 | -$0.72 | -$0.62 | 13.89% | $0.00 | $31.30K | $0.00 | -100.00% | 02/27/2025 | |
RCKT | Rocket Pharmaceuticals | -$0.75 | -$0.76 | -$0.71 | 6.58% | $0.00 | $700.00K | $0.00 | -100.00% | 11/07/2024 | |
RCKT | Rocket Pharmaceuticals | -$0.82 | -$0.72 | -$0.74 | -2.78% | $0.00 | — | $0.00 | — | 08/05/2024 | |
RCKT | Rocket Pharmaceuticals | -$0.73 | -$0.69 | -$0.66 | 4.35% | $0.00 | — | $0.00 | — | 05/06/2024 | |
RCKT | Rocket Pharmaceuticals | -$0.92 | -$0.79 | -$0.64 | 18.99% | $0.00 | — | $0.00 | — | 02/26/2024 | |
RCKT | Rocket Pharmaceuticals | -$0.87 | -$0.81 | -$0.75 | 7.41% | $0.00 | — | $0.00 | — | 11/06/2023 | |
RCKT | Rocket Pharmaceuticals | -$0.83 | -$0.79 | -$0.82 | -3.80% | $0.00 | — | $0.00 | — | 08/10/2023 | |
RCKT | Rocket Pharmaceuticals | -$0.67 | -$0.86 | -$0.73 | 15.12% | $0.00 | — | $0.00 | — | 05/04/2023 | |
RCKT | Rocket Pharmaceuticals | -$0.69 | -$0.80 | -$0.92 | -15.00% | $0.00 | — | $0.00 | — | 02/27/2023 | |
RCKT | Rocket Pharmaceuticals | -$0.79 | -$0.79 | -$0.87 | -10.13% | $0.00 | — | $0.00 | — | 11/03/2022 | |
RCKT | Rocket Pharmaceuticals | -$0.55 | -$0.68 | -$0.83 | -22.06% | $0.00 | — | $0.00 | — | 08/08/2022 | |
RCKT | Rocket Pharmaceuticals | -$0.65 | -$0.71 | -$0.67 | 5.63% | $0.00 | — | $0.00 | — | 05/05/2022 | |
RCKT | Rocket Pharmaceuticals | -$1.08 | -$0.76 | -$0.69 | 9.21% | $0.00 | — | $0.00 | — | 02/24/2022 | |
RCKT | Rocket Pharmaceuticals | -$0.53 | -$0.58 | -$0.79 | -36.21% | $0.00 | — | $0.00 | — | 11/03/2021 | |
RCKT | Rocket Pharmaceuticals | -$0.45 | -$0.65 | -$0.55 | 15.38% | $0.00 | — | $0.00 | — | 08/09/2021 | |
RCKT | Rocket Pharmaceuticals | -$0.45 | -$0.71 | -$0.65 | 8.45% | $0.00 | — | $0.00 | — | 05/10/2021 | |
RCKT | Rocket Pharmaceuticals | -$0.39 | -$0.52 | -$1.08 | -107.69% | $0.00 | — | $0.00 | — | 02/25/2021 |
Rocket Pharmaceuticals (RCKT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $-0.45 | $-0.50 | 10.0 % |
| Q2 | 2025-08-07 | $-0.62 | $-0.55 | -12.7 % |
| Q1 | 2025-05-08 | $-0.56 | $-0.58 | 3.45 % |
| Q4 | 2025-02-27 | $-0.62 | $-0.72 | 13.9 % |
Rocket Pharmaceuticals (RCKT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $0 | $250.00K | -100.0 % |
| Q2 | 2025-08-07 | $0 | $4.36M | -100.0 % |
| Q1 | 2025-05-08 | $0 | $800.00K | -100.0 % |
| Q4 | 2025-02-27 | $0 | $31.30K | -100.0 % |
FAQ
When is Rocket Pharmaceuticals (NASDAQ:RCKT) reporting earnings?
Rocket Pharmaceuticals (RCKT) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2025 for Q3.
What were the latest earnings per share (EPS) for Rocket Pharmaceuticals (NASDAQ:RCKT)?
Rocket Pharmaceuticals (RCKT) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2025 for Q3 and the Actual EPS was $-0.45, which beat the estimate of $-0.50.
What were Rocket Pharmaceuticals’s (NASDAQ:RCKT) revenues?
Rocket Pharmaceuticals (RCKT) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2025 for Q3 and the Actual Revenue was $0K, which missed the estimate of $250K.
Browse earnings estimates, EPS, and revenue on all stocks.
